| 000 | 02479nim a2200529 a 4500 | ||
|---|---|---|---|
| 001 | HST8216 | ||
| 003 | UkLoHST | ||
| 006 | m o h | ||
| 007 | cr nna|||||||| | ||
| 007 | sr |mnnnnnzne| | ||
| 008 | 210304s2021 enk|||||o||h||||||||eng d | ||
| 028 | 5 | 0 |
_a8216 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)4580 | ||
| 040 |
_aUkLoHST _beng _cUkLoHST |
||
| 100 | 1 |
_aBaric, Ralph, _u(University of North Carolina at Chapel Hill, USA) _4spk |
|
| 245 | 1 | 0 |
_aCOVID-19 epidemiology and variants _h[electronic resource] : _bnew challenges and future of the pandemic / _can interview with Ralph Baric. |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2021. |
||
| 300 | _a1 online resource (1 streaming audio file (18 min.)). | ||
| 490 | 1 |
_aInterviews on Covid-19, _x2056-452X |
|
| 500 | _aAudio interview. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Emergence of new variants and their new evolutionarily advantageous traits -- Probability of the emergence of additional variants and a new strain of SARS-CoV-2 -- Potential immune escape mechanisms of a theoretical new SARS-CoV-2 strain -- What can governments and individuals do to reduce the probability of emergence of additional variants -- Efficacy shown to date by COVID-19 vaccines and their projected impact in controlling the pandemic -- Update on current COVID-19 treatments (including convalescent antibody therapy, Remdesivir and dexamethasone) and the importance of the time window for their administration. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 650 | 0 | _aCoronaviruses. | |
| 650 | 0 |
_aCOVID-19 (Disease) _xEpidemiology. |
|
| 650 | 0 |
_aCOVID-19 (Disease) _xResearch. |
|
| 650 | 0 | _aCOVID-19 Pandemic, 2020- | |
| 650 | 2 | _aCoronavirus Infections. | |
| 650 | 2 | _aCOVID-19 Vaccines. | |
| 650 | 2 |
_aCOVID-19 _xepidemiology. |
|
| 650 | 2 |
_aCOVID-19 _xtransmission. |
|
| 650 | 2 |
_aCOVID-19 _xvirology. |
|
| 650 | 2 | _aDexamethasone. | |
| 650 | 2 | _aDrug Development. | |
| 650 | 2 | _aDrug Resistance, Viral. | |
| 650 | 2 | _aGenetic Variation. | |
| 650 | 2 | _aMutation. | |
| 650 | 2 | _aPandemics. | |
| 650 | 2 | _aremdesivir. | |
| 650 | 2 | _aSARS-CoV-2 variants. | |
| 650 | 2 |
_aSARS-CoV-2 _xgenetics. |
|
| 650 | 2 |
_aSARS-CoV-2 _xpathogenicity. |
|
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pInterviews on Covid-19. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/4580/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1060/ _3Series |
| 999 |
_c75838 _d75838 |
||